LIGHT Signals Directly to Intestinal Epithelia to Cause Barrier Dysfunction via Cytoskeletal and Endocytic Mechanisms

Gastroenterology

Volumn 132, Issue 7, 2007, Pages 2383-2394

  Schwarz, Brad T ^a   Wang, Fengjun ^a,b   Shen, Le ^a   Clayburgh, Daniel R ^a   Su, Liping ^a   Wang, Yingmin ^a   Fu, Yang Xin ^a   Turner, Jerrold R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b SOUTHWEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; GAMMA INTERFERON; LYMPHOTOXIN BETA; MYOSIN II; MYOSIN LIGHT CHAIN KINASE; OCCLUDIN; PROTEIN DERIVATIVE; PROTEIN LIGHT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENDOCYTOSIS; ENTERITIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

EID: 34250190636     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.02.052     Document Type: Article

References (70)

1. Wang J., Anders R.A., Wu Q., Peng D., Cho J.H., Sun Y., Karaliukas R., Kang H.S., Turner J.R., and Fu Y.X. Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest 113 (2004) 826-835
2. Shaikh R.B., Santee S., Granger S.W., Butrovich K., Cheung T., Kronenberg M., Cheroutre H., and Ware C.F. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 167 (2001) 6330-6337
3. Wang J., Anders R.A., Wang Y., Turner J.R., Abraham C., Pfeffer K., and Fu Y.X. The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease. J Immunol 174 (2005) 8173-8182
4. Granger S.W., Butrovich K.D., Houshmand P., Edwards W.R., and Ware C.F. Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis. J Immunol 167 (2001) 5122-5128
5. Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., McLeod R.S., Griffiths A.M., Green T., Brettin T.S., Stone V., Bull S.B., Bitton A., Williams C.N., Greenberg G.R., Cohen Z., Lander E.S., Hudson T.J., and Siminovitch K.A. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 66 (2000) 1863-1870
6. Cohavy O., Zhou J., Granger S.W., Ware C.F., and Targan S.R. LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestine. J Immunol 173 (2004) 251-258
7. Wang J., and Fu Y.X. Tumor necrosis factor family members and inflammatory bowel disease. Immunol Rev 204 (2005) 144-155
8. Mackay F., Browning J.L., Lawton P., Shah S.A., Comiskey M., Bhan A.K., Mizoguchi E., Terhorst C., and Simpson S.J. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 115 (1998) 1464-1475
9. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 27 (1992) 721-726
10. Yacyshyn B.R., and Meddings J.B. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology 108 (1995) 132-137
11. Wyatt J., Vogelsang H., Hubl W., Waldhoer T., and Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341 (1993) 1437-1439
12. Hollander D. Permeability in Crohn's disease: altered barrier functions in healthy relatives?. Gastroenterology 104 (1993) 1848-1851
13. Buhner S., Buning C., Genschel J., Kling K., Herrmann D., Dignass A., Kuechler I., Krueger S., Schmidt H.H., and Lochs H. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?. Gut 55 (2006) 342-347
14. Suenaert P., Bulteel V., Vermeire S., Noman M., Van Assche G., and Rutgeerts P. Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent. Inflamm Bowel Dis 11 (2005) 667-673
15. Hollander D. Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg?. Am J Gastroenterol 97 (2002) 1867-1868
16. Suenaert P., Bulteel V., Lemmens L., Noman M., Geypens B., Van Assche G., Geboes K., Ceuppens J.L., and Rutgeerts P. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol 97 (2002) 2000-2004
17. Heller F., Florian P., Bojarski C., Richter J., Christ M., Hillenbrand B., Mankertz J., Gitter A.H., Burgel N., Fromm M., Zeitz M., Fuss I., Strober W., and Schulzke J.D. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129 (2005) 550-564
18. Prasad S., Mingrino R., Kaukinen K., Hayes K.L., Powell R.M., MacDonald T.T., and Collins J.E. Inflammatory processes have differential effects on Claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 85 (2005) 1139-1162
19. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., and Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171 (2003) 6164-6172
20. Clayburgh D.R., Musch M.W., Leitges M., Fu Y.X., and Turner J.R. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest 116 (2006) 2682-2694
21. Nusrat A., Turner J.R., and Madara J.L. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279 (2000) G851-G857
22. Utech M., Ivanov A.I., Samarin S.N., Bruewer M., Turner J.R., Mrsny R.J., Parkos C.A., and Nusrat A. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: Myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16 (2005) 5040-5052
23. Mullin J.M., and Snock K.V. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 50 (1990) 2172-2176
24. Taylor C.T., Dzus A.L., and Colgan S.P. Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterology 114 (1998) 657-668
25. Abreu M.T., Palladino A.A., Arnold E.T., Kwon R.S., and McRoberts J.A. Modulation of barrier function during Fas-mediated apoptosis in human intestinal epithelial cells. Gastroenterology 119 (2000) 1524-1536
26. Gitter A.H., Bendfeldt K., Schulzke J.D., and Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J 14 (2000) 1749-1753
27. Gitter A.H., Wullstein F., Fromm M., and Schulzke J.D. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 121 (2001) 1320-1328
28. Blair S.A., Kane S.V., Clayburgh D.R., and Turner J.R. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 86 (2006) 191-201
29. Ma T.Y., Boivin M.A., Ye D., Pedram A., and Said H.M. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 288 (2005) G422-G430
30. Wang F., Graham W.V., Wang Y., Witkowski E.D., Schwarz B.T., and Turner J.R. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166 (2005) 409-419
31. Wang F., Schwarz B.T., Graham W.V., Wang Y., Su L., Clayburgh D.R., Abraham C., and Turner J.R. IFN-gamma-induced TNFR2 upregulation is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131 (2006) 1153-1163
32. Zolotarevsky Y., Hecht G., Koutsouris A., Gonzalez D.E., Quan C., Tom J., Mrsny R.J., and Turner J.R. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123 (2002) 163-172
33. Clayburgh D.R., Barrett T.A., Tang Y., Meddings J.B., Van Eldik L.J., Watterson D.M., Clarke L.L., Mrsny R.J., and Turner J.R. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest 115 (2005) 2702-2715
34. Zhang M., Guo R., Zhai Y., and Yang D. LIGHT sensitizes IFNgamma-mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of anti-apoptosis Bcl-2 family members. Cancer Lett 195 (2003) 201-210
35. Turner J.R., Rill B.K., Carlson S.L., Carnes D., Kerner R., Mrsny R.J., and Madara J.L. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol 273 (1997) C1378-C1385
36. Peterson M.D., and Mooseker M.S. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci 102 (1992) 581-600
37. Berglund J.J., Riegler M., Zolotarevsky Y., Wenzl E., and Turner J.R. Regulation of human jejunal transmucosal resistance and MLC phosphorylation by Na-glucose cotransport. Am J Physiol Gastrointest Liver Physiol 281 (2001) G1487-G1493
38. Graham W.V., Wang F., Clayburgh D.R., Cheng J.X., Yoon B., Wang Y., Lin A., and Turner J.R. Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter. J Biol Chem 281 (2006) 26205-26215
39. Wang Y., Subudhi S.K., Anders R.A., Lo J., Sun Y., Blink S., Wang J., Liu X., Mink K., Degrandi D., Pfeffer K., and Fu Y.X. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest 115 (2005) 711-717
40. Futterer A., Mink K., Luz A., Kosco-Vilbois M.H., and Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9 (1998) 59-70
41. Mankertz J., Tavalali S., Schmitz H., Mankertz A., Riecken E.O., Fromm M., and Schulzke J.D. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci 113 (2000) 2085-2090
42. Ma T.Y., Iwamoto G.K., Hoa N.T., Akotia V., Pedram A., Boivin M.A., and Said H.M. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286 (2004) G367-G376
43. Owens D.W., Wilson N.J., Hill A.J., Rugg E.L., Porter R.M., Hutcheson A.M., Quinlan R.A., van Heel D., Parkes M., Jewell D.P., Campbell S.S., Ghosh S., Satsangi J., and Lane E.B. Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients. J Cell Sci 117 (2004) 1989-1999
44. Shen L., Black E.D., Witkowski E.D., Lencer W.I., Guerriero V., Schneeberger E.E., and Turner J.R. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119 (2006) 2095-2106
45. Bruewer M., Utech M., Ivanov A.I., Hopkins A.M., Parkos C.A., and Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 19 (2005) 923-933
46. Ivanov A.I., Nusrat A., and Parkos C.A. Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell 15 (2004) 176-188
47. Shen L., and Turner J.R. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell 16 (2005) 3919-3936
48. West M.A., Bretscher M.S., and Watts C. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol 109 (1989) 2731-2739
49. Wang L.H., Rothberg K.G., and Anderson R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123 (1993) 1107-1117
50. Davies P.J., Davies D.R., Levitzki A., Maxfield F.R., Milhaud P., Willingham M.C., and Pastan I.H. Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones. Nature 283 (1980) 162-167
51. Olson T.S., Reuter B.K., Scott K.G., Morris M.A., Wang X.M., Hancock L.N., Burcin T.L., Cohn S.M., Ernst P.B., Cominelli F., Meddings J.B., Ley K., and Pizarro T.T. The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med 203 (2006) 541-552
52. Irvine E.J., and Marshall J.K. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 119 (2000) 1740-1744
53. Madsen K.L., Malfair D., Gray D., Doyle J.S., Jewell L.D., and Fedorak R.N. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 5 (1999) 262-270
54. Ferrier L., Mazelin L., Cenac N., Desreumaux P., Janin A., Emilie D., Colombel J.F., Garcia-Villar R., Fioramonti J., and Bueno L. Stress-induced disruption of colonic epithelial barrier: Role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology 125 (2003) 795-804
55. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., and Coffman R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1 (1994) 553-562
56. Zeissig S., Burgel N., Gunzel D., Richter J., Mankertz J., Wahnschaffe U., Kroesen A.J., Zeitz M., Fromm M., and Schulzke J.D. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56 (2007) 61-72
57. Weber C.R., and Turner J.R. Inflammatory bowel disease: is it really just another break in the wall?. Gut 56 (2007) 6-8
58. Hopkins A.M., Walsh S.V., Verkade P., Boquet P., and Nusrat A. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci 116 (2003) 725-742
59. Furuse M., Fujimoto K., Sato N., Hirase T., and Tsukita S. Overexpression of occludin, a tight junction-associated integral membrane protein, induces the formation of intracellular multilamellar bodies bearing tight junction-like structures. J Cell Sci 109 (1996) 429-435
60. McCarthy K.M., Skare I.B., Stankewich M.C., Furuse M., Tsukita S., Rogers R.A., Lynch R.D., and Schneeberger E.E. Occludin is a functional component of the tight junction. J Cell Sci 109 (1996) 2287-2298
61. Chen Y., Merzdorf C., Paul D.L., and Goodenough D.A. COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos. J Cell Biol 138 (1997) 891-899
62. Wong V., and Gumbiner B.M. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136 (1997) 399-409
63. Huber D., Balda M.S., and Matter K. Occludin modulates transepithelial migration of neutrophils. J Biol Chem 275 (2000) 5773-5778
64. Li D., and Mrsny R.J. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J Cell Biol 148 (2000) 791-800
65. Murata M., Kojima T., Yamamoto T., Go M., Takano K., Osanai M., Chiba H., and Sawada N. Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro. Exp Cell Res 310 (2005) 140-151
66. Van Itallie C.M., and Anderson J.M. Occludin confers adhesiveness when expressed in fibroblasts. J Cell Sci 110 (1997) 1113-1121
67. Yu A.S., McCarthy K.M., Francis S.A., McCormack J.M., Lai J., Rogers R.A., Lynch R.D., and Schneeberger E.E. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol 288 (2005) C1231-C1241
68. Rajasekaran S.A., Barwe S.P., Gopal J., Ryazantsev S., Schneeberger E.E., and Rajasekaran A.K. Na,K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292 (2007) G124-G133
69. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., and Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11 (2000) 4131-4142
70. Schulzke J.D., Gitter A.H., Mankertz J., Spiegel S., Seidler U., Amasheh S., Saitou M., Tsukita S., and Fromm M. Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta 1669 (2005) 34-42